<code id='8C4D3297DC'></code><style id='8C4D3297DC'></style>
    • <acronym id='8C4D3297DC'></acronym>
      <center id='8C4D3297DC'><center id='8C4D3297DC'><tfoot id='8C4D3297DC'></tfoot></center><abbr id='8C4D3297DC'><dir id='8C4D3297DC'><tfoot id='8C4D3297DC'></tfoot><noframes id='8C4D3297DC'>

    • <optgroup id='8C4D3297DC'><strike id='8C4D3297DC'><sup id='8C4D3297DC'></sup></strike><code id='8C4D3297DC'></code></optgroup>
        1. <b id='8C4D3297DC'><label id='8C4D3297DC'><select id='8C4D3297DC'><dt id='8C4D3297DC'><span id='8C4D3297DC'></span></dt></select></label></b><u id='8C4D3297DC'></u>
          <i id='8C4D3297DC'><strike id='8C4D3297DC'><tt id='8C4D3297DC'><pre id='8C4D3297DC'></pre></tt></strike></i>

          focus

          focus

          author:hotspot    Page View:8
          Rep. Larry Bucshon (R-Ind.) received a significant amount of campaign donations from the pharmaceutical industry in the second quarter of 2023. House Television via AP

          WASHINGTON — The pharmaceutical industry has been flooding the campaign coffers of Rep. Larry Bucshon, a cardiothoracic surgeon and Republican from Indiana, according to a STAT analysis of this quarter’s filings.

          CEOs of pharmaceutical giants, executives of the brand-drug lobby PhRMA, and companies’ political action committees all gave in higher-than-usual numbers to the rank-and-file House member last quarter. The total was nearly $56,000 between April 14 and June 30.

          advertisement

          Bucshon is a member of the House Energy & Commerce Committee, which works on drug pricing issues, and the GOP Doctors Caucus, but he doesn’t hold leadership positions in either.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          ChatGPT in medicine: STAT answers readers' burning questions
          ChatGPT in medicine: STAT answers readers' burning questions

          MikeReddyforSTATArtificialintelligenceisoftendescribedasablackbox:anunknowable,mysteriousforcethatop

          read more
          With psoriasis trial ahead, Alumis raises $259 million
          With psoriasis trial ahead, Alumis raises $259 million

          Aclose-upofpsoriasisonahand.AdobeSanFranciscostartupAlumisInc.hasraised$259millioninabidtobestbigpha

          read more
          Hepatitis C has a cure — but many Americans still lack access to it
          Hepatitis C has a cure — but many Americans still lack access to it

          AdobeIn2005,NickVoyleswasdiagnosedwithhepatitisCafterbeingreleasedfromfiveyearsofincarceration.Anurs

          read more

          Readout Newsletter: Amylyx, Alto Neuro, and Eli Lilly for the Oscars

          KristofferTripplaar/APWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiot